A recent study also demonstrated that miR-135b might be a key downstream effector of oncogenic pathways, such as the Wnt and PTEN/PI3K signaling pathways, and might serve as a potential target for CRC treatment [32]. The gene discussed is PTEN; the disease is colorectal carcinoma.